New hope for advanced cancers: first human trial of TH9619 begins
NCT ID NCT07151040
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 27 times
Summary
This early-phase trial tests a new drug called TH9619 in 43 adults with advanced solid tumors (colorectal, head and neck, lung, or stomach cancer) that have not responded to prior treatment. The main goal is to find a safe dose and check for side effects. Researchers will also watch for any signs that the drug shrinks tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Universitario Fundacion Jimenez Diaz
RECRUITINGMadrid, Spain
-
Institut Gustave Roussy
RECRUITINGVillejuif, France
-
Newcastle University
RECRUITINGNewcastle upon Tyne, United Kingdom
-
Vall D Hebron Institute Of Oncology
RECRUITINGBarcelona, Spain
Conditions
Explore the condition pages connected to this study.